Clinical trial
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
NCT05354778 is registered in ClinicalTrials.gov with Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
- Lead sponsor
- Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 16, 2022
- Completion date
- July 31, 2026
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthcare-associated pneumonia, ventilator associated pneumonia